Shamburg News · 8-K filed Oct 14, 2026, 8:00 AM EDT

Profound Medical Announces TULSA Abstracts at 15th Interventional MRI Symposium

PROF · Profound Medical Corp.

  • Other event
  • Reg FD disclosure
  • Materiality: low

Profound Medical Corp. announced on October 14, 2026 that five abstracts on its TULSA-PRO system were presented at the 15th Interventional MRI Symposium in Boston, Massachusetts. The presentations covered CARE Registry data, Mayo Clinic single-center studies, six-month outcomes from the randomized CAPTAIN trial versus robotic radical prostatectomy, and technical validation on a Siemens 0.55T Free.Max MRI platform. The information was furnished under Item 7.01 as Regulation FD disclosure and is not deemed filed.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001171843-26-006615.

Written from the filing by Shamburg Markets. Figures are as reported by the company.